The Exit of Multinational Pharmaceutical Companies from Pakistan – Part 3 – Asrar Qureshi’s Blog Post #1293

Asrar Qureshi’s blog discusses the exit of multinational pharmaceutical companies from Pakistan and the country’s potential to attract them back. Highlighting necessary reforms in pricing, regulation, and clinical research, it stresses a long-term vision for the pharmaceutical sector as vital for economic growth and public health security. Collaboration between domestic and multinational firms is essential for success.
Share
Scientist pipetting liquid into a tray in a laboratory setting with lab equipment and computer displaying graphs
View Post

Why Multinational Pharmaceutical Companies Are Leaving Pakistan – Asrar Qureshi’s Blog Post #1291

Asrar Qureshi’s blog post discusses the exit of multinational pharmaceutical companies from the Pakistani market, highlighting historical contributions, major exits, and the challenges faced by these firms, such as drug price controls and currency depreciation. Despite local companies acquiring many brands, concerns about access to innovative therapies and a decline in research presence persist.
Share